Integral Derivatives’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Integral Derivatives’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-25,100	Closed	-$157K	–	1241
2015 Q4	$157K	Hold	25,100	–	–	﹤0.01%	958
2015 Q3	$147K	Buy	+25,100	New	+$193K	﹤0.01%	988
2015 Q1	–	Sell	-19,800	Closed	-$136K	–	1545
2014 Q4	$136K	Hold	19,800	–	–	﹤0.01%	1271
2014 Q3	$107K	Hold	19,800	–	–	﹤0.01%	1326
2014 Q2	$126K	Hold	19,800	–	–	﹤0.01%	1255
2014 Q1	$160K	Sell	19,800 -35,900	-64%	-$280K	﹤0.01%	1201
2013 Q4	$380K	Buy	+55,700	New	+$301K	0.01%	1142

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Integral Derivatives's ARIA Position: Q1 2015 in Review

Integral Derivatives sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2015, closing a stake of 16,684 shares — an estimated $115K sold.

Integral Derivatives first reported a position in ARIA in Q1 2014 and held it in 4 quarters. The position peaked at $119K in Q1 2014. 193 funds tracked by Wall St. Rank hold ARIA as of Q1 2015.

Integral Derivatives reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
Integral Derivatives sold 16,684 Ariad Pharmaceuticals Inc shares in Q1 2015, an estimated $115K.
Integral Derivatives first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 4 quarters.
Integral Derivatives's Ariad Pharmaceuticals Inc position peaked at $119K in Q1 2014.
193 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2015.

Based on Integral Derivatives's 13F filing for Q1 2015, filed 20 Apr 2015.